A high level of MIP mRNA was associated with poor OS in all histological subtype gastric cancer patients, HR = 1.55 (1.29–1.86)[32] and all ovarian cancer patients, HR = 1.15 (1.01–1.31),[33] but better RFS in all histological subtype breast cancer.[34] The expression of MIP is extremely low in the kidney, and the biological performance of MIP in ccRCC has not yet been studied. This evidence concerns the gene MIP and gastric cancer.